𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA

✍ Scribed by Pai, S I; Hung, C-F; Wu, T-C; Monie, A; Kang, T H; Chung, J-Y

Book ID
109855255
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
749 KB
Volume
17
Category
Article
ISSN
0969-7128

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Enhanced DNA vaccine potency by mannosyl
Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration
✍ Yoshiyuki Hattori; Shigeru Kawakami; Yan Lu; Kazumi Nakamura; Fumiyoshi Yamashit πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 184 KB

## Abstract ## Background Here we describe a novel DNA vaccine formulation that can enhance cytotoxic T lymphocyte (CTL) activity through efficient gene delivery to dendritic cells (DCs) by mannose receptor‐mediated endocytosis. ## Methods Ovalbumin (OVA) was selected as a model antigen for vacc

Enhancement of DNA vaccine potency by an
Enhancement of DNA vaccine potency by antigen linkage to IFN-Ξ³-inducible protein-10
✍ Tae Heung Kang; Keon Woo Kim; Hyun Cheol Bae; Seung-Yong Seong; Tae Woo Kim πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 642 KB

## Abstract DNA vaccines have emerged as an attractive approach to generate antigen‐specific T‐cell immune response. Nevertheless, the potency of DNA vaccines still needs to be improved for cancer immunotherapy. In this study, we explored whether functional linkage of a Th1‐polarizing chemokine, IP

DNA binding of regulatory factors intera
DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines
✍ O. Blanchet; J. F. Bourge; H. Zinszner; Z. Tatari; L. Degos; P. Paul πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 812 KB

Tumor cells frequently show a lack of surface class-I major histocompatibility complex (MHC) antigen expression. These molecules are key recognition structures for immune rejection of tumor cells and their absence at the surface of tumor cells could favor the progression of tumors. We have analyzed